A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Chu, Fong Fong, Ph.D. Bookmark and Share

Laboratory of Fong Fong Chu, Ph.D.

Glutathione Peroxidase in Mouse Inflammatory Bowel Disease and Radiation Protection
Inflammatory bowel disease (IBD) is consisted of Crohn’s disease, which always involves the ileum, and ulcerative colitis, which always involves the colon.  About one to two per thousand Americans are diagnosed with IBD each year, and most people diagnosed of Crohn’s disease are between 15-30 years old, when most people diagnosed of ulcerative colitis are in their 30s (www.ccfa.org).  Although IBD is not a life-threatening disease, it is painful, needs long-term management, and increases cancer risk in the ileum, the colon, and the rectum.
 
To better manage this disease, we need to better understand the cause and the progression of this disease. Many animal IBD models have been generated and analyzed for IBD etiology and treatment. Most studied animal IBD models are mouse models for ulcerative colitis.  There are only a couple of mouse models for Crohn’s disease, SAMP1/Yit mice and TNFΔARE mice, which overexpress tumor necrosis factor. We have recently generated a new mouse model for Crohn’s disease, by disruption of genes encoding for two Se-dependent glutathione peroxidases (GPXs), Gpx1 and Gpx2.  Gpx1/2-double knockout (DKO) mice have more severe ilealitis than colitis, and ten-times more of ileal tumors than colonic tumors.
 
There are three major factors in IBD etiology: genetic, environmental, and immunological; all have been confirmed in Gpx1/2-DKO mice.  Among the mouse inbred lines that we have studied, Gpx1/2-DKO mice on a pure 129/SvJ (129) genetic background have the worst pathology and symptoms; DKO mice on a mixed C57BL/6J (B6) and 129 (B6.129) genetic background still have intermediate symptom and pathology; when B6 DKO mice have very mild disease.  This disease is induced by luminal microflora, since germ-free Gpx1/2-DKO mice are disease-free.  Although these DKO mice are highly sensitive to certain microflora, the identity of the pathogens remains to be elusive.
 
Another important environmental factor affecting IBD outcome is the diet.  We have found DKO mice on defined diets have much better health than those on commercial rodent chows. Since dietary modulation provides the best health for these DKO mice than many conventional and experimental drugs for IBD, we plan to identify the component of diet that cause ileocolitis.
 
Increased in reactive oxygen species (ROS) has been observed in inflamed intestinal mucosa in IBD patients, however, it is believed to be caused by inflammation. ROS is also known to activate many pro-inflammatory cytokines presumably by activation of nuclear factor (NF) κB pathway, thus the ROS generated from inflammatory cells adds fuel to the fire and further damage the tissue. We are investigating that whether GPX protects intestinal epithelial cells from oxidative stress, and what are the downstream genes affected by GPX activity.
 
In addition to the role of GPX in prevention of ileocolitis that we have recently discovered, the antioxidant activity of GPX has long been suspected to protect cells against radiation damage. However, there is little evidence to support this claim.  Additionally, whether the radioprotective effect of Amifostine, a small molecule with superoxide dismutase activity, depends on GPX to reduce hydrogen peroxide is not known.  We plan to evaluate the role of GPX in protection of intestinal epithelial cells against γ-irradiation in near future.
 

Fong Fong Chu, Ph.D. Lab Members

Avo Artinyan, M.D.
Surgical Oncology Fellow
Ph 626-256-HOPE (4673)
Ext. 67100
Fax 626-930-5330
AArtinyan@coh.org
 
Steve Esworthy, Ph.D.
Assistant Research Scientist
Ph 626-256-HOPE (4673)
Ext. 62819
Fax 626-930-5330
SEsworthy@coh.org
 
Qiang Gao, M.D., Ph.D.
Research Fellow
Ph 626-256-HOPE (4673)
Ext. 65589
Fax 626-930-5330
QGao@coh.org
 
Byung-Wook Kim, M.S.
Research Associate I
Ph 626-256-HOPE (4673)
Ext. 62955
Fax 626-930-5330
bkim@coh.org
 
Marucha Sanchez
Research Associate I
Ph 626-256-HOPE (4673)
Ext. 60412
Fax 626-930-5330
msanchez2@coh.org
 

Chu, Fong Fong, Ph.D.

Laboratory of Fong Fong Chu, Ph.D.

Glutathione Peroxidase in Mouse Inflammatory Bowel Disease and Radiation Protection
Inflammatory bowel disease (IBD) is consisted of Crohn’s disease, which always involves the ileum, and ulcerative colitis, which always involves the colon.  About one to two per thousand Americans are diagnosed with IBD each year, and most people diagnosed of Crohn’s disease are between 15-30 years old, when most people diagnosed of ulcerative colitis are in their 30s (www.ccfa.org).  Although IBD is not a life-threatening disease, it is painful, needs long-term management, and increases cancer risk in the ileum, the colon, and the rectum.
 
To better manage this disease, we need to better understand the cause and the progression of this disease. Many animal IBD models have been generated and analyzed for IBD etiology and treatment. Most studied animal IBD models are mouse models for ulcerative colitis.  There are only a couple of mouse models for Crohn’s disease, SAMP1/Yit mice and TNFΔARE mice, which overexpress tumor necrosis factor. We have recently generated a new mouse model for Crohn’s disease, by disruption of genes encoding for two Se-dependent glutathione peroxidases (GPXs), Gpx1 and Gpx2.  Gpx1/2-double knockout (DKO) mice have more severe ilealitis than colitis, and ten-times more of ileal tumors than colonic tumors.
 
There are three major factors in IBD etiology: genetic, environmental, and immunological; all have been confirmed in Gpx1/2-DKO mice.  Among the mouse inbred lines that we have studied, Gpx1/2-DKO mice on a pure 129/SvJ (129) genetic background have the worst pathology and symptoms; DKO mice on a mixed C57BL/6J (B6) and 129 (B6.129) genetic background still have intermediate symptom and pathology; when B6 DKO mice have very mild disease.  This disease is induced by luminal microflora, since germ-free Gpx1/2-DKO mice are disease-free.  Although these DKO mice are highly sensitive to certain microflora, the identity of the pathogens remains to be elusive.
 
Another important environmental factor affecting IBD outcome is the diet.  We have found DKO mice on defined diets have much better health than those on commercial rodent chows. Since dietary modulation provides the best health for these DKO mice than many conventional and experimental drugs for IBD, we plan to identify the component of diet that cause ileocolitis.
 
Increased in reactive oxygen species (ROS) has been observed in inflamed intestinal mucosa in IBD patients, however, it is believed to be caused by inflammation. ROS is also known to activate many pro-inflammatory cytokines presumably by activation of nuclear factor (NF) κB pathway, thus the ROS generated from inflammatory cells adds fuel to the fire and further damage the tissue. We are investigating that whether GPX protects intestinal epithelial cells from oxidative stress, and what are the downstream genes affected by GPX activity.
 
In addition to the role of GPX in prevention of ileocolitis that we have recently discovered, the antioxidant activity of GPX has long been suspected to protect cells against radiation damage. However, there is little evidence to support this claim.  Additionally, whether the radioprotective effect of Amifostine, a small molecule with superoxide dismutase activity, depends on GPX to reduce hydrogen peroxide is not known.  We plan to evaluate the role of GPX in protection of intestinal epithelial cells against γ-irradiation in near future.
 

Lab Members

Fong Fong Chu, Ph.D. Lab Members

Avo Artinyan, M.D.
Surgical Oncology Fellow
Ph 626-256-HOPE (4673)
Ext. 67100
Fax 626-930-5330
AArtinyan@coh.org
 
Steve Esworthy, Ph.D.
Assistant Research Scientist
Ph 626-256-HOPE (4673)
Ext. 62819
Fax 626-930-5330
SEsworthy@coh.org
 
Qiang Gao, M.D., Ph.D.
Research Fellow
Ph 626-256-HOPE (4673)
Ext. 65589
Fax 626-930-5330
QGao@coh.org
 
Byung-Wook Kim, M.S.
Research Associate I
Ph 626-256-HOPE (4673)
Ext. 62955
Fax 626-930-5330
bkim@coh.org
 
Marucha Sanchez
Research Associate I
Ph 626-256-HOPE (4673)
Ext. 60412
Fax 626-930-5330
msanchez2@coh.org
 
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • The lack of a practical way to produce and store enough stem cells for larger-scale therapies and clinical trials is creating a bottleneck in stem cell research. A new grant to City of Hope from the California Institute for Regenerative Medicine will help solve that problem. The $899,728 grant, awarded Thursday...
  • City of Hope has long known what researchers increasingly are confirming: Gardens and natural surroundings help seriously ill people recover from their treatment ordeals. Already a trailblazer in the creation of beautiful natural spaces for cancer patients and their families, on Jan. 15,  City of Hope dedicated...
  • Despite advances in surgery, radiation and drug therapy, brain tumors remain particularly challenging to treat. This is due to the tumor’s location, which can limit localized therapies’ effectiveness, and the blood-brain barrier, which blocks many cancer-fighting drugs’ passage from the bloodstream to the tumor...
  • We’ve seen it in science fiction: The aliens begin terra-forming a planet to create a friendly habitat that gives them, not the inhabitants, all the advantages when the colonization begins. Turns out, cancer does essentially the same thing when it metastasizes, according to new research from City of Hope. The f...
  • Equipping the immune system to fight cancer – a disease that thrives on mutations and circumventing the body’s natural defenses – is within reach. In fact, City of Hope researchers are testing one approach in clinical trials now. Scientists take a number of steps to turn cancer patients’ T cells – white b...
  • As treatments for lung cancer become more targeted and effective, the need for better technology to detect lung cancer mutations becomes increasingly important. A new clinical study at City of Hope is examining the feasibility of using blood and urine tests to detect lung cancer mutations, potentially allowing ...
  • When it comes to breast cancer risk, insulin levels may matter more than weight, new research has found. The study from Imperial College London School of Public Health, published in the journal Cancer Research, indicates that metabolic health – not a person’s weight or body mass index – increases breast cancer ...
  • No one ever plans to have cancer – and there’s never a good time. For Homa Sadat, her cancer came at a particularly bad time: just one year after losing her father to the pancreatic cancer he had battled for two years. She was working a grueling schedule managing three commercial office buildings. She’d just [&...
  • Patients at City of Hope – most of whom are fighting cancer – rely on more than 37,000 units of blood and platelets each year for their treatment and survival. Every one of those units comes from family, friends or someone who traded an hour or so of their time and a pint of their […]
  • Surgery is vital in the treatment of cancer – it’s used to help diagnose, treat and even prevent the disease – so a new colorectal cancer study linking a decrease in surgeries for advanced cancer to increased survival rates may raise more questions than it answers for some patients. The surgery-and-surviv...
  • Age is the single greatest risk factor overall for cancer; our chances of developing the disease rise steeply after age 50. For geriatric oncology nurse Peggy Burhenn, the meaning is clear: Cancer is primarily a geriatric condition. That’s why she is forging inroads in the care of older adults with cancer. Burh...
  • One of American’s great sportscasters, Stuart Scott, passed away from recurrent cancer of the appendix at the young age of 49. His cancer was diagnosed when he was only 40 years old. It was found during an operation for appendicitis. His courageous fight against this disease began in 2007, resumed again with an...
  • When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. With the lump dismissed as a harmless cyst, she didn’t think about it again until she was at a restaurant six months later and felt […]
  • What most people call a “bone marrow transplant” is not actually a transplant of bone marrow; it is instead the transplantation of what’s known as hematopoietic stem cells. Such cells are often taken from bone marrow, but not always. Hematopoietic stem cells are simply immature cells that can ...
  • Doctors have long known that women with a precancerous condition called atypical hyperplasia have an elevated risk of breast cancer. Now a new study has found that the risk is more serious than previously thought. Hyperplasia itself is an overgrowth of cells; atypical hyperplasia is an overgrowth in a distorted...